Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended Decembe... (quisition of American Medical Instrument...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006

Date:3/13/2008

quisition of American Medical Instruments Holdings, Inc. ("AMI"); and any other factors referenced in our annual information form and other filings with the applicable Canadian securities regulatory authorities or the SEC. Given these uncertainties, assumptions and risk factors, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained in this press release to reflect future results, events or developments.

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX, ANP) please visit our website at http://www.angiotech.com.

CONTACT: Deirdre Neary, Manager, Investor Relations and Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
2. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
3. Angiotech announces results for the fourth quarter ended December 31, 2007
4. Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
6. Angiotech and Symphony Medical Announce Licensing Agreement
7. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
8. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech to participate in Bank of America 2007 Credit Conference
11. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook

Post Your Comments:

(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...

(Date:11/24/2009)... SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceutic...TO)hasallowedthepatentapplicationfor,itsnano-parti...gyisahighlyefficientapproachtoincorporatepeptideso...aldeliveryofdrugs,otherwiseadministeredasinjection...iedtomanymacromoleculardrugssuchasinsulin,interfer...

(Date:11/24/2009)... SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxy...on(SFDA)hasapprovedthe,investigationalnewdrugappli...ovativeinsulinformulationtotreatdiabetes.ThisIND,a...alstudy. , Diabetesisadisordercharacteristico...nsofdiabetesoftenresultinseveremicro-and,macro-vas...

(Date:11/24/2009)... The FBI recently approved the P...ies participating in or generating DNA records for... Madison, WI USA (PRWEB) -- The FBI recent...em for use by laboratories participating in, or g...System (NDIS). NDIS currently contains more than s...

Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2 The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3 The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4 Biolaxy Secures IND Approval for Oral Insulin 2 NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2

[0] The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close [0] US Patent Allowed for NOD Tech [0] Biolaxy Secures IND Approval for Oral Insulin [0] NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database

...h Ltd.,(Alimentary Health), the development stage ...ecent study evaluating the use of probiotics in th...found that Bifidobacterium,infantis 35624, the Ali...fantis(R), is the only probiotic currently able to...oms. Alimentary Health is a leader in pioneering ...

... Between Citations and Pr... 16 Thomson,Scientific, part of The Thomson Corpo...r of information solutions to the worldwide resear...two out of four Nobel Prize,category winners this ... This year,s Physiology or Medicine award winners...

...ence, Inc.,today announced the release and immedia...dition, a high-value product extension of Oncomine...archers. Oncomine Research,Premium Edition include...Pathway Analysis software and full support for Onc... custom and proprietary concepts in a secure,envir...

Other Biology Technology:Recent Study Confirms Alimentary Health's Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome 2 Recent Study Confirms Alimentary Health's Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome 3 Recent Study Confirms Alimentary Health's Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome 4 Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006 2 Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006 3 Compendia Bioscience Announces the Release and Availability of Oncomine(TM) Research Premium Edition 2

Recent Study Confirms Alimentary Health's Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006 Compendia Bioscience Announces the Release and Availability of Oncomine(TM) Research Premium Edition

(Date:11/25/2009)...essors recently received funding from the National...eficial to understanding the environment. The thre..., assistant professor in the Department of Biologi...parate research projects. , His first project, t...d Functions from the Leaf to the Landscape," will ...

(Date:11/24/2009)... named 12 new grant recipients for 2009. The award...k across a broad spectrum of lupus research. All w...tential to drive scientific discovery to ultimatel...systemic lupus. , The 2009 grants go to both new...on and include interdisciplinary and highly promis...

(Date:11/24/2009)...eries from collapsing have been true life-savers. ...eeded -- once the arteries are strengthened, they ...ice but to leave them in place. , Prof. Meital Z...omedical Engineering has developed a new patent-pe...,re needed, then dissolves. , "Our new composite...

[0] Kent State University professors focus research on the environment with grants totaling $890,000 [2] Lupus Research Institute announces 2009 novel research grants [0] A coating for life

... preterm birth are staggering. In Canada, outlays ...are estimated to be almost $2 billion per year. In... study, researchers found that giving nitroglyceri...o significant improvement in their baby’s health. ...ry issue of the American Journal of Obstetrics &am...

...olving the use of a mathematical model, suggest th...ugs might be the best way to deal with an emerging...not triggered a worldwide human epidemic yet becau...uire this ability, it would take 6-8 months to dev...blic health officials therefore need to consider h...

...stal and long-lived deep-ocean fish species in the...wind systems and water temperatures, according to ...ates this week. , “We have drawn correlations betw...vironmental conditions ?faster growth in waters ab...th below 1,000 metres,?says lead author, Dr Ron Th...

Other Biology News:Fish growth changes enhanced by climate change 2

Plastic that degrades in seawater could be boon for cruise industry and others Bird flu -- Call for antiviral drugs to be shared Fish growth changes enhanced by climate change

...vy duty stainless-steel shaker flask clips, purpos...h speeds. All clips are equipped with a top retai... bottom retainer spring, and silicon tubing spring...are. Clips include the required mounting screws.,...

Mouse Anti-DIPHTHERIA TOXIN (A SUBUNIT) Monoclonal Antibody, Unconjugated, Clone 8G2 from AbD Serotec

... EnzChek Lysozyme Assay Kit (E-22013) provides,res...of lysozyme,activity in solution. This fluorescenc... 20 U/mL (Figure 1). The assay,measures lysozyme a...hich are labeled to such a degree that the fluores...

...(5')ppp(5')G (Cap Analog) is used for the synthesi...tion reactions. Substitution of cap analog for a l...on reaction results in the incorporation of the ca...ts. Capped mRNAs are generally translated more eff...

Biology Products:

2800ml Flask Clip from Thermo Scientific Mouse Anti-DIPHTHERIA TOXIN (A SUBUNIT) Monoclonal Antibody, Unconjugated, Clone 8G2 from AbD Serotec Lysozyme Fluorometric (Green) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)m7G(5)ppp(5)G (Cap Analog) from Ambion

Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended Decembe...(quisition of American Medical Instrument...)